Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.
Convergent’s CONV01-α is being developed as a new treatment for prostate cancer. Credit: NMK-Studio/Shutterstock. NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an expanded strategic
The popular low-calorie sweetener xylitol was linked to increased cardiovascular and thrombotic risk, a series of experiments showed. Metabolomic studies linked xylitol intake to higher